Non-invasive Prenatal Testing (NIPT) Market by Product & Service (Consumables (Assay Kits & Reagents), Instruments (NGS Systems, Microarrays)), Method (Biochemical Screening, Cell-free DNA Test), End User (Diagnostic Labs) - Global Forecast to 2029
The global non-invasive prenatal testing (NIPT) market is projected to reach USD 14.1 billion by 2029 from USD 7.2 billion in 2024 at a CAGR of 14.5%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2021 and June 2024. Players in the global non-invasive prenatal testing (NIPT) market have employed various strategies to expand their global footprint and increase their market shares such as partnerships, agreements, divestitures, expansions, and acquisitions.
“The Service segment accounted for the second-largest market share in the non-invasive prenatal testing (NIPT) market.”
By products & service, service segment holds the second largest market share in the non-invasive prenatal testing (NIPT) market due to the growing preference for outsourcing complex diagnostic procedures to specialized service providers. These providers offer advanced technology and expertise, ensuring accurate and timely results, which are crucial for expectant parents making informed decisions about their pregnancies. Additionally, service providers often have the infrastructure to handle high volumes of tests, which can be more cost-effective for healthcare facilities than maintaining in-house capabilities. This outsourcing trend drives the substantial market share held by the service segment in the NIPT market.
“cfDNA in maternal plasma test segment of the non-invasive prenatal testing (NIPT) market is expected to witness the fastest CAGR.”
By method type, the cfDNA in maternal plasma test segment has witnessed the fastest growth rate in the non-invasive prenatal testing (NIPT) market. This is largely due to its high accuracy and safety. Unlike traditional invasive methods such as amniocentesis, cfDNA testing involves a simple blood draw from the mother, minimizing risk to both the mother and the fetus. This non-invasive approach can detect a wide range of genetic conditions early in pregnancy with high sensitivity and specificity, leading to increased adoption by healthcare providers and expectant parents seeking reliable, low-risk prenatal screening options.
“The Microdeletion syndrome segment of the non-invasive prenatal testing (NIPT) market accounted for the second largest market share.”
Based on application type, the microdeletion syndrome segment has accounted for the second largest market share in the Non-invasive Prenatal Testing (NIPT) market primarily due to the increasing awareness and advancements in genetic testing technologies. Microdeletion syndromes, which involve the deletion of small chromosome segments, can lead to significant developmental disorders and health issues in newborns. As a result, expectant parents are increasingly opting for NIPT to detect these conditions early, allowing for better preparedness and management. Moreover, NIPT offers a safe, non-invasive alternative to traditional diagnostic methods, further driving its adoption.
“Diagnostic laboratories segment of the non-invasive prenatal testing (NIPT) market holds the largest market share.”
By end user type, the diagnostic laboratories segment has accounted for the largest market share, in the non-invasive prenatal testing (NIPT) market, due to their advanced technological capabilities and infrastructure, which enable accurate and efficient testing. These laboratories are equipped with cutting-edge equipment and specialized personnel, ensuring high-quality results. Additionally, they often have established relationships with healthcare providers and insurance companies, streamlining the process for patients and physicians. This integration of superior technology, expertise, and streamlined operations makes diagnostic laboratories the preferred choice for NIPT, thereby securing the largest market share in this segment.
“APAC region to have the third largest market share in the non-invasive prenatal testing (NIPT) market, by region.”
In the APAC region, the non-invasive prenatal testing (NIPT) market has grown significantly. This is mainly because of the region's rapidly growing population and increasing awareness of prenatal health. With countries like China and India having large and expanding populations, there is a heightened demand for advanced prenatal testing solutions. The growing middle class in these countries is also becoming more health-conscious and willing to invest in high-quality healthcare services, including non-invasive prenatal testing. Additionally, the rising incidence of advanced maternal age and a greater emphasis on early disease detection further drive the demand for NIPT. These factors collectively contribute to APAC's leading position in the global market for non-invasive prenatal testing.
A breakdown of the primary participants (supply side) for the non-invasive prenatal testing (NIPT) market referred to for this report is provided below:
The prominent players in the non-invasive prenatal testing (NIPT) market include Illumina, Inc. (US), Natera, Inc. (US), Laboratory Corporation of America Holdings (US), Eurofins Sceintific (France), F. Hoffmann-La Roche AG (Switzerland). Revvity, Inc. (US), Thermo Fisher Scientific Inc (US), Agilent Technologies (US), GE Healthcare Technologies Inc. (US), Quest Diagnostics Incorporated (US), Sonic Healthcare Limited (Australia), Centogene N.V. (Germany), Qiagen N.V. (Germany), Pathwest Laboratory Medicine WA (Australia), Myriad Genetics Inc. (US), BGI Genomics Co., Ltd. (China), Oxford Nanopore Technologies Plc. (UK), Medgenome (India), Neuberg Diagnostics (India), Anngroad Gene Technology (China), Next Biosciences (South Africa), Lilac Insights (India), Invitae Corporation (US), Baylor Genetics (US), Raven (US).
Research Coverage:
The market analysis examines the non-invasive prenatal testing (NIPT) market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product and service, method type, application type, end user type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the non-invasive prenatal testing (NIPT) market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
“The Service segment accounted for the second-largest market share in the non-invasive prenatal testing (NIPT) market.”
By products & service, service segment holds the second largest market share in the non-invasive prenatal testing (NIPT) market due to the growing preference for outsourcing complex diagnostic procedures to specialized service providers. These providers offer advanced technology and expertise, ensuring accurate and timely results, which are crucial for expectant parents making informed decisions about their pregnancies. Additionally, service providers often have the infrastructure to handle high volumes of tests, which can be more cost-effective for healthcare facilities than maintaining in-house capabilities. This outsourcing trend drives the substantial market share held by the service segment in the NIPT market.
“cfDNA in maternal plasma test segment of the non-invasive prenatal testing (NIPT) market is expected to witness the fastest CAGR.”
By method type, the cfDNA in maternal plasma test segment has witnessed the fastest growth rate in the non-invasive prenatal testing (NIPT) market. This is largely due to its high accuracy and safety. Unlike traditional invasive methods such as amniocentesis, cfDNA testing involves a simple blood draw from the mother, minimizing risk to both the mother and the fetus. This non-invasive approach can detect a wide range of genetic conditions early in pregnancy with high sensitivity and specificity, leading to increased adoption by healthcare providers and expectant parents seeking reliable, low-risk prenatal screening options.
“The Microdeletion syndrome segment of the non-invasive prenatal testing (NIPT) market accounted for the second largest market share.”
Based on application type, the microdeletion syndrome segment has accounted for the second largest market share in the Non-invasive Prenatal Testing (NIPT) market primarily due to the increasing awareness and advancements in genetic testing technologies. Microdeletion syndromes, which involve the deletion of small chromosome segments, can lead to significant developmental disorders and health issues in newborns. As a result, expectant parents are increasingly opting for NIPT to detect these conditions early, allowing for better preparedness and management. Moreover, NIPT offers a safe, non-invasive alternative to traditional diagnostic methods, further driving its adoption.
“Diagnostic laboratories segment of the non-invasive prenatal testing (NIPT) market holds the largest market share.”
By end user type, the diagnostic laboratories segment has accounted for the largest market share, in the non-invasive prenatal testing (NIPT) market, due to their advanced technological capabilities and infrastructure, which enable accurate and efficient testing. These laboratories are equipped with cutting-edge equipment and specialized personnel, ensuring high-quality results. Additionally, they often have established relationships with healthcare providers and insurance companies, streamlining the process for patients and physicians. This integration of superior technology, expertise, and streamlined operations makes diagnostic laboratories the preferred choice for NIPT, thereby securing the largest market share in this segment.
“APAC region to have the third largest market share in the non-invasive prenatal testing (NIPT) market, by region.”
In the APAC region, the non-invasive prenatal testing (NIPT) market has grown significantly. This is mainly because of the region's rapidly growing population and increasing awareness of prenatal health. With countries like China and India having large and expanding populations, there is a heightened demand for advanced prenatal testing solutions. The growing middle class in these countries is also becoming more health-conscious and willing to invest in high-quality healthcare services, including non-invasive prenatal testing. Additionally, the rising incidence of advanced maternal age and a greater emphasis on early disease detection further drive the demand for NIPT. These factors collectively contribute to APAC's leading position in the global market for non-invasive prenatal testing.
A breakdown of the primary participants (supply side) for the non-invasive prenatal testing (NIPT) market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–25%, and Tier 3–40%
- By Designation: C-level–45%, Director Level–25%, and Others–30%
- By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America-10%, and Middle East & Africa_ 7%
- By End User Type: Diagnostic Laboratory-65%, Hospitals-35%
- By Designation: Laboratories Technicians-55%, Doctor-45%
- By Region: North America–34%, Europe–27%, Asia Pacific–23%, Latin America-9%, and Middle East & Africa-7%
The prominent players in the non-invasive prenatal testing (NIPT) market include Illumina, Inc. (US), Natera, Inc. (US), Laboratory Corporation of America Holdings (US), Eurofins Sceintific (France), F. Hoffmann-La Roche AG (Switzerland). Revvity, Inc. (US), Thermo Fisher Scientific Inc (US), Agilent Technologies (US), GE Healthcare Technologies Inc. (US), Quest Diagnostics Incorporated (US), Sonic Healthcare Limited (Australia), Centogene N.V. (Germany), Qiagen N.V. (Germany), Pathwest Laboratory Medicine WA (Australia), Myriad Genetics Inc. (US), BGI Genomics Co., Ltd. (China), Oxford Nanopore Technologies Plc. (UK), Medgenome (India), Neuberg Diagnostics (India), Anngroad Gene Technology (China), Next Biosciences (South Africa), Lilac Insights (India), Invitae Corporation (US), Baylor Genetics (US), Raven (US).
Research Coverage:
The market analysis examines the non-invasive prenatal testing (NIPT) market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product and service, method type, application type, end user type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the non-invasive prenatal testing (NIPT) market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
- Analysis of key Drivers: Drivers (High risk of chromosomal abnormalities with increasing maternal age, Growing preference for non-invasive techniques over invasive methods, Improving reimbursement scenario for NIPT, Programs focusing on increasing awareness of NIPT), Restrains (High cost of procedures, Lack of insurance coverage), Opportunities (Untapped emerging markets, Technological Advancements), Challenges (Reliability of test results especially in obese women, Lack of skilled professionals) influencing the growth of the non-invasive prenatal testing (NIPT) market.
- Market Penetration: Comprehensive information on the product portfolios of the leading companies in the non-invasive prenatal testing (NIPT) market. The report breaks down the market by product and service type, method types, application types, end user types and region.
- Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the non-invasive prenatal testing (NIPT) market.
- Market Development: Comprehensive data on attractive rising markets broken down by product and service type, method types, application types, end user types and region.
- Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the non-invasive prenatal testing (NIPT) market.
- Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main non-invasive prenatal testing (NIPT) products manufacturers.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 NON-INVASIVE PRENATAL TESTING MARKET OVERVIEW
4.2 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
4.3 GEOGRAPHIC MIX: NON-INVASIVE PRENATAL TESTING MARKET,
2024–2029 (USD MILLION)
4.4 NON-INVASIVE PRENATAL TESTING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS, 2024 VS. 2029
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High risk of chromosomal abnormalities with increasing
maternal age
5.2.1.2 Growing preference for noninvasive techniques over invasive methods
5.2.1.3 Improving reimbursement scenario
5.2.1.4 Initiatives to spread awareness
5.2.2 RESTRAINTS
5.2.2.1 High cost of procedures
5.2.2.2 Lack of insurance coverage
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Reliability of test results
5.2.4.2 Lack of skilled professionals
5.3 INDUSTRY TRENDS
5.3.1 DETECTION BEYOND TRISOMIES
5.3.2 EARLIER GESTATIONAL AGE TESTING
5.3.3 INTEGRATION WITH NGS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Cell-free DNA analysis
5.4.1.2 NGS
5.4.1.3 Digital PCR
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Microfluidics
5.4.2.2 Nanotechnology
5.4.2.3 Epigenetics analysis
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Ultrasound imaging
5.4.3.2 Genome editing (CRISPR/Cas9)
5.4.3.3 Liquid biopsy
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 PORTER’S FIVE FORCE ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.9.2 BUYING CRITERIA
5.10 REGULATORY LANDSCAPE
5.10.1 REGULATORY ANALYSIS
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
5.13 PRICING ANALYSIS
5.13.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
5.13.2 AVERAGE SELLING PRICE TREND, BY REGION
5.14 REIMBURSEMENT ANALYSIS
5.15 KEY CONFERENCES AND EVENTS, 2024–2025
5.16 UNMET NEEDS/END-USER EXPECTATIONS
5.17 CASE STUDIES
5.17.1 EVALUATION OF NIFTY TEST IN DETECTING FETAL CHROMOSOMAL ABNORMALITIES IN ASIAN POPULATIONS
5.17.2 CLINICAL UTILITY OF HARMONY PRENATAL TEST IN A COHORT OF PREGNANT WOMEN
5.17.3 ASSESSMENT OF PANORAMA TEST IN DETECTING FETAL GENETIC CONDITIONS
5.18 ADJACENT MARKET ANALYSIS
5.19 INVESTMENT & FUNDING SCENARIO
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.21 IMPACT OF ARTIFICIAL INTELLIGENCE ON NON-INVASIVE PRENATAL TESTING MARKET
6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 CONSUMABLES
6.2.1.1 Assay kits & reagents
6.2.1.1.1 Frequent use of reagents and assay kits to drive market
6.2.1.2 Disposables
6.2.1.2.1 Need for contamination-free workflow to boost demand for disposables
6.2.2 INSTRUMENTS
6.2.2.1 Ultrasound devices
6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety to drive market
6.2.2.2 NGS systems
6.2.2.2.1 Rising use of NGS in NIPT to drive market
6.2.2.3 PCR instruments
6.2.2.3.1 Increasing research in prenatal genetic testing to boost market growth
6.2.2.4 Microarrays
6.2.2.4.1 Flexibility of chips and short processing times to support usage
6.2.2.5 Other instruments
6.3 SERVICES
6.3.1 NORTH AMERICA TO REGISTER HIGHEST DEMAND FOR TESTING SERVICES
7 NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD
7.1 INTRODUCTION
7.2 ULTRASOUND DETECTION
7.2.1 ULTRASOUND DETECTION TO DOMINATE NIPT MARKET
7.3 BIOCHEMICAL SCREENING TESTS
7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH
7.4 CFDNA IN MATERNAL PLASMA TESTS
7.4.1 CFDNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER HIGHEST CAGR
8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 TRISOMY
8.2.1 TRISOMY TO HOLD LARGEST SHARE OF APPLICATIONS MARKET AND SHOW HIGHEST GROWTH
8.3 MICRODELETION SYNDROME
8.3.1 INCREASING AWARENESS TO SUPPORT DEMAND FOR TESTING
8.4 OTHER APPLICATIONS
9 NON-INVASIVE PRENATAL TESTING MARKET, BY END USER
9.1 INTRODUCTION
9.2 DIAGNOSTIC LABORATORIES
9.2.1 RISING RESEARCH INTENSITY TO DRIVE USAGE OF NIPT PRODUCTS IN DIAGNOSTIC LABS
9.3 HOSPITALS
9.3.1 RISING INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO PROPEL MARKET
10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
10.2.2 US
10.2.2.1 High incidence of chromosomal syndromes to drive demand
10.2.3 CANADA
10.2.3.1 Unfavorable reimbursement scenario for NIPT to challenge market growth
10.3 EUROPE
10.3.1 EUROPE: MACROECONOMIC OUTLOOK
10.3.2 UK
10.3.2.1 High incidence of genetic abnormalities to increase demand for prenatal testing
10.3.3 GERMANY
10.3.3.1 Strong R&D and increasing healthcare spending to drive market
10.3.4 FRANCE
10.3.4.1 Favorable insurance coverage for prenatal testing to increase adoption of NIPT
10.3.5 ITALY
10.3.5.1 Favorable funding scenario for genomics to drive market
10.3.6 SPAIN
10.3.6.1 Rising funding and expanding research infrastructure to propel market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
10.4.2 JAPAN
10.4.2.1 Rising maternal age to propel incidence of chromosomal disorders
10.4.3 CHINA
10.4.3.1 China to register highest growth in Asia Pacific market
10.4.4 INDIA
10.4.4.1 Rising disposable income and demand for better health to support market growth
10.4.5 AUSTRALIA
10.4.5.1 Strong research ecosystem for NIPT to drive market
10.4.6 SOUTH KOREA
10.4.6.1 Increasing scope for genomic research to support market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
10.5.2 BRAZIL
10.5.2.1 Rising focus on clinical genomics to drive demand for NIPT
10.5.3 MEXICO
10.5.3.1 High incidence of Down syndrome to propel demand
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
10.6.2 GCC COUNTRIES
10.6.2.1 Launch of genomic initiatives to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NON-INVASIVE PRENATAL TESTING MARKET
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 R&D EXPENDITURE OF KEY PLAYERS
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.6.5.1 Company footprint
11.6.5.2 Product & service footprint
11.6.5.3 Method footprint
11.6.5.4 Application footprint
11.6.5.5 End-user footprint
11.6.5.6 Region footprint
11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.7.1 PROGRESSIVE COMPANIES
11.7.2 DYNAMIC COMPANIES
11.7.3 STARTING BLOCKS
11.7.4 RESPONSIVE COMPANIES
11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8 VALUATION & FINANCIAL METRICS
11.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT & SERVICE LAUNCHES
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 ILLUMINA, INC.
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.3.2 Expansions
12.1.1.3.3 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 NATERA, INC.
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product & service launches and approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 EUROFINS SCIENTIFIC
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Service launches
12.1.4.3.2 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 F. HOFFMANN-LA ROCHE AG
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 REVVITY, INC.
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.3.2 Deals
12.1.7 THERMO FISHER SCIENTIFIC INC.
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 AGILENT TECHNOLOGIES
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 GE HEALTHCARE TECHNOLOGIES INC.
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product & service launches and approvals
12.1.9.3.2 Expansions
12.1.10 QUEST DIAGNOSTICS INCORPORATED
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches
12.1.10.3.2 Deals
12.1.11 SONIC HEALTHCARE LIMITED
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.11.3.2 Expansions
12.1.12 CENTOGENE N.V.
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Deals
12.1.12.3.3 Other developments
12.1.13 QIAGEN N.V.
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product launches
12.1.13.3.2 Deals
12.1.13.3.3 Expansions
12.1.14 PATHWEST LABORATORY MEDICINE WA
12.1.14.1 Business overview
12.1.14.2 Products & services offered
12.1.15 MYRIAD GENETICS, INC.
12.1.15.1 Business overview
12.1.15.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 BGI GENOMICS CO., LTD.
12.2.2 OXFORD NANOPORE TECHNOLOGIES PLC
12.2.3 MEDGENOME
12.2.4 NEUBERG DIAGNOSTICS
12.2.5 ANNOROAD GENE TECHNOLOGY
12.2.6 NEXT BIOSCIENCES
12.2.7 LILAC INSIGHTS
12.2.8 INVITAE CORPORATION
12.2.9 BAYLOR GENETICS
12.2.10 RAVGEN
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 2 RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE
TABLE 3 INCIDENCE RATE OF TRISOMY
TABLE 4 COMPARISON OF NONINVASIVE AND INVASIVE PRENATAL TESTING
TABLE 5 NIPT REIMBURSEMENT SCENARIO, BY COUNTRY
TABLE 6 PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)
TABLE 7 NIPT MARKET: ECOSYSTEM ANALYSIS
TABLE 8 NIPT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS
TABLE 10 KEY BUYING CRITERIA FOR NIPT PRODUCTS
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 16 LIST OF PATENTS IN NIPT MARKET, 2014–2024
TABLE 17 IMPORT AND EXPORT DATA FOR NEXT-GENERATION SEQUENCING PRODUCTS,
BY COUNTRY
TABLE 18 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY TYPE
TABLE 19 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY REGION
TABLE 20 NIPT MARKET: LIST OF KEY CONFERENCES AND EVENTS DURING 2024–2025
TABLE 21 NIPT MARKET: UNMET NEEDS
TABLE 22 NIPT MARKET: END-USER EXPECTATIONS
TABLE 23 NIPT MARKET: IMPACT AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE
TABLE 24 NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 25 NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 26 NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 27 NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 28 NIPT PRODUCTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 29 NIPT PRODUCTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 30 NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 31 NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 32 NIPT CONSUMABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 33 NIPT CONSUMABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 34 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 35 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 36 DISPOSABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 37 DISPOSABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 38 NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 39 NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 40 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 41 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 42 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 43 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 44 NGS SYSTEMS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 45 NGS SYSTEMS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 46 PCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 47 PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 48 MICROARRAYS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 49 MICROARRAYS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 50 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 51 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 52 NIPT SERVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 53 NIPT SERVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 54 NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 55 NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 56 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 57 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 58 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION)
TABLE 59 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION)
TABLE 60 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION)
TABLE 61 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION)
TABLE 62 NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 63 NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 64 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 65 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 66 NIPT MARKET FOR MICRODELETION SYNDROME,
BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 67 NIPT MARKET FOR MICRODELETION SYNDROME,
BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 68 NIPT MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 69 NIPT MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 70 NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 71 NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 72 NIPT MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 73 NIPT MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 74 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 75 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 76 NIPT MARKET, BY REGION, 2021–2023 (USD MILLION)
TABLE 77 NIPT MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 78 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 79 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 80 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 81 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 83 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 84 NORTH AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 85 NORTH AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 87 NORTH AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 89 NORTH AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 91 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 93 NORTH AMERICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 94 US: KEY MACROINDICATORS
TABLE 95 US: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 96 US: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 97 US: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 98 US: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 99 US: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 100 US: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 101 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 102 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 103 US: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 104 US: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 105 US: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 106 US: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 107 US: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 108 US: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 109 CANADA: KEY MACROINDICATORS
TABLE 110 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 111 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 112 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 113 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 114 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 115 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 116 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 117 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 118 CANADA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 119 CANADA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 120 CANADA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 121 CANADA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 122 CANADA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 123 CANADA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 124 EUROPE: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 125 EUROPE: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 126 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 127 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 128 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 129 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 130 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 131 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 132 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 133 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 134 EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 135 EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 136 EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 137 EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 138 EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 139 EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 140 UK: KEY MACROINDICATORS
TABLE 141 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 142 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 143 UK: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 144 UK: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 145 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 146 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 147 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 148 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 149 UK: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 150 UK: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 151 UK: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 152 UK: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 153 UK: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 154 UK: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 155 GERMANY: KEY MACROINDICATORS
TABLE 156 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 157 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 158 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 159 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 160 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 161 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 162 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 163 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 164 GERMANY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 165 GERMANY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 166 GERMANY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 167 GERMANY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 168 GERMANY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 169 GERMANY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 170 FRANCE: KEY MACROINDICATORS
TABLE 171 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 172 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 173 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 174 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 175 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 176 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 177 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 178 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 179 FRANCE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 180 FRANCE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 181 FRANCE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 182 FRANCE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 183 FRANCE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 184 FRANCE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 185 ITALY: KEY MACROINDICATORS
TABLE 186 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 187 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 188 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 189 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 190 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 191 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 192 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 193 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 194 ITALY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 195 ITALY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 196 ITALY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 197 ITALY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 198 ITALY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 199 ITALY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 200 SPAIN: KEY MACROINDICATORS
TABLE 201 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 202 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 203 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 204 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 205 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 206 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 207 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 208 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 209 SPAIN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 210 SPAIN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 211 SPAIN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 212 SPAIN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 213 SPAIN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 214 SPAIN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 215 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 216 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 217 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 218 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 219 REST OF EUROPE: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 220 REST OF EUROPE: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 221 REST OF EUROPE: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 222 REST OF EUROPE: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 223 REST OF EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 224 REST OF EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 225 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 226 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 227 REST OF EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 228 REST OF EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 230 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 232 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 233 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 234 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 235 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 236 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 237 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 238 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 239 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 240 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 241 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 242 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 244 ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 245 JAPAN: KEY MACROINDICATORS
TABLE 246 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 247 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 248 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 249 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 250 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 251 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 252 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 253 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 254 JAPAN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 255 JAPAN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 256 JAPAN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 257 JAPAN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 258 JAPAN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 259 JAPAN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 260 CHINA: KEY MACROINDICATORS
TABLE 261 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 262 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 263 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 264 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 265 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 266 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 267 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 268 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 269 CHINA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 270 CHINA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 271 CHINA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 272 CHINA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 273 CHINA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 274 CHINA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 275 INDIA: KEY MACROINDICATORS
TABLE 276 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 277 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 278 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 279 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 280 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 281 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 282 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 283 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 284 INDIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 285 INDIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 286 INDIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 287 INDIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 288 INDIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 289 INDIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 290 AUSTRALIA: KEY MACROINDICATORS
TABLE 291 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 292 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 293 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 294 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 295 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 296 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 297 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 298 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 299 AUSTRALIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 300 AUSTRALIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 301 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 302 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 303 AUSTRALIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 304 AUSTRALIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 305 SOUTH KOREA: KEY MACROINDICATORS
TABLE 306 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 307 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 308 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 309 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 310 SOUTH KOREA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 311 SOUTH KOREA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 312 SOUTH KOREA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 313 SOUTH KOREA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 314 SOUTH KOREA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 315 SOUTH KOREA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 316 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 317 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 318 SOUTH KOREA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 319 SOUTH KOREA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE,
2021–2023 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE,
2024–2029 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 327 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 328 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION,
2021–2023 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION,
2024–2029 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 334 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 335 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 336 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 337 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 338 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 339 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 340 LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 341 LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 342 LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 343 LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 344 LATIN AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 345 LATIN AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 346 LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 347 LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 348 LATIN AMERICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 349 LATIN AMERICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 350 BRAZIL: KEY MACROINDICATORS
TABLE 351 BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 352 BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 353 BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 354 BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 355 BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 356 BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 357 BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 358 BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 359 BRAZIL: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 360 BRAZIL: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 361 BRAZIL: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 362 BRAZIL: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 363 BRAZIL: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 364 BRAZIL: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 365 MEXICO: KEY MACROINDICATORS
TABLE 366 MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 367 MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 368 MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 369 MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 370 MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 371 MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 372 MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 373 MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 374 MEXICO: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 375 MEXICO: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 376 MEXICO: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 377 MEXICO: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 378 MEXICO: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 379 MEXICO: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 380 REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 381 REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 382 REST OF LATIN AMERICA: NIPT PRODUCTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 383 REST OF LATIN AMERICA: NIPT PRODUCTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 384 REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 385 REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 386 REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 387 REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 388 REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 389 REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 390 REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION,
2021–2023 (USD MILLION)
TABLE 391 REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION,
2024–2029 (USD MILLION)
TABLE 392 REST OF LATIN AMERICA: NIPT MARKET, BY END USER,
2021–2023 (USD MILLION)
TABLE 393 REST OF LATIN AMERICA: NIPT MARKET, BY END USER,
2024–2029 (USD MILLION)
TABLE 394 MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2021–2023 (USD MILLION)
TABLE 395 MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 396 MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 397 MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 398 MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE,
2021–2023 (USD MILLION)
TABLE 399 MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE,
2024–2029 (USD MILLION)
TABLE 400 MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 NON-INVASIVE PRENATAL TESTING MARKET OVERVIEW
4.2 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
4.3 GEOGRAPHIC MIX: NON-INVASIVE PRENATAL TESTING MARKET,
2024–2029 (USD MILLION)
4.4 NON-INVASIVE PRENATAL TESTING MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS, 2024 VS. 2029
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 High risk of chromosomal abnormalities with increasing
maternal age
5.2.1.2 Growing preference for noninvasive techniques over invasive methods
5.2.1.3 Improving reimbursement scenario
5.2.1.4 Initiatives to spread awareness
5.2.2 RESTRAINTS
5.2.2.1 High cost of procedures
5.2.2.2 Lack of insurance coverage
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.3.2 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Reliability of test results
5.2.4.2 Lack of skilled professionals
5.3 INDUSTRY TRENDS
5.3.1 DETECTION BEYOND TRISOMIES
5.3.2 EARLIER GESTATIONAL AGE TESTING
5.3.3 INTEGRATION WITH NGS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Cell-free DNA analysis
5.4.1.2 NGS
5.4.1.3 Digital PCR
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Microfluidics
5.4.2.2 Nanotechnology
5.4.2.3 Epigenetics analysis
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Ultrasound imaging
5.4.3.2 Genome editing (CRISPR/Cas9)
5.4.3.3 Liquid biopsy
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 PORTER’S FIVE FORCE ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.9.2 BUYING CRITERIA
5.10 REGULATORY LANDSCAPE
5.10.1 REGULATORY ANALYSIS
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
5.13 PRICING ANALYSIS
5.13.1 AVERAGE SELLING PRICE TREND, BY PRODUCT
5.13.2 AVERAGE SELLING PRICE TREND, BY REGION
5.14 REIMBURSEMENT ANALYSIS
5.15 KEY CONFERENCES AND EVENTS, 2024–2025
5.16 UNMET NEEDS/END-USER EXPECTATIONS
5.17 CASE STUDIES
5.17.1 EVALUATION OF NIFTY TEST IN DETECTING FETAL CHROMOSOMAL ABNORMALITIES IN ASIAN POPULATIONS
5.17.2 CLINICAL UTILITY OF HARMONY PRENATAL TEST IN A COHORT OF PREGNANT WOMEN
5.17.3 ASSESSMENT OF PANORAMA TEST IN DETECTING FETAL GENETIC CONDITIONS
5.18 ADJACENT MARKET ANALYSIS
5.19 INVESTMENT & FUNDING SCENARIO
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.21 IMPACT OF ARTIFICIAL INTELLIGENCE ON NON-INVASIVE PRENATAL TESTING MARKET
6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 PRODUCTS
6.2.1 CONSUMABLES
6.2.1.1 Assay kits & reagents
6.2.1.1.1 Frequent use of reagents and assay kits to drive market
6.2.1.2 Disposables
6.2.1.2.1 Need for contamination-free workflow to boost demand for disposables
6.2.2 INSTRUMENTS
6.2.2.1 Ultrasound devices
6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety to drive market
6.2.2.2 NGS systems
6.2.2.2.1 Rising use of NGS in NIPT to drive market
6.2.2.3 PCR instruments
6.2.2.3.1 Increasing research in prenatal genetic testing to boost market growth
6.2.2.4 Microarrays
6.2.2.4.1 Flexibility of chips and short processing times to support usage
6.2.2.5 Other instruments
6.3 SERVICES
6.3.1 NORTH AMERICA TO REGISTER HIGHEST DEMAND FOR TESTING SERVICES
7 NON-INVASIVE PRENATAL TESTING MARKET, BY METHOD
7.1 INTRODUCTION
7.2 ULTRASOUND DETECTION
7.2.1 ULTRASOUND DETECTION TO DOMINATE NIPT MARKET
7.3 BIOCHEMICAL SCREENING TESTS
7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH
7.4 CFDNA IN MATERNAL PLASMA TESTS
7.4.1 CFDNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER HIGHEST CAGR
8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 TRISOMY
8.2.1 TRISOMY TO HOLD LARGEST SHARE OF APPLICATIONS MARKET AND SHOW HIGHEST GROWTH
8.3 MICRODELETION SYNDROME
8.3.1 INCREASING AWARENESS TO SUPPORT DEMAND FOR TESTING
8.4 OTHER APPLICATIONS
9 NON-INVASIVE PRENATAL TESTING MARKET, BY END USER
9.1 INTRODUCTION
9.2 DIAGNOSTIC LABORATORIES
9.2.1 RISING RESEARCH INTENSITY TO DRIVE USAGE OF NIPT PRODUCTS IN DIAGNOSTIC LABS
9.3 HOSPITALS
9.3.1 RISING INCIDENCE OF GENETIC DISORDERS AND INCREASING FOCUS ON PRENATAL TESTING TO PROPEL MARKET
10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
10.2.2 US
10.2.2.1 High incidence of chromosomal syndromes to drive demand
10.2.3 CANADA
10.2.3.1 Unfavorable reimbursement scenario for NIPT to challenge market growth
10.3 EUROPE
10.3.1 EUROPE: MACROECONOMIC OUTLOOK
10.3.2 UK
10.3.2.1 High incidence of genetic abnormalities to increase demand for prenatal testing
10.3.3 GERMANY
10.3.3.1 Strong R&D and increasing healthcare spending to drive market
10.3.4 FRANCE
10.3.4.1 Favorable insurance coverage for prenatal testing to increase adoption of NIPT
10.3.5 ITALY
10.3.5.1 Favorable funding scenario for genomics to drive market
10.3.6 SPAIN
10.3.6.1 Rising funding and expanding research infrastructure to propel market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
10.4.2 JAPAN
10.4.2.1 Rising maternal age to propel incidence of chromosomal disorders
10.4.3 CHINA
10.4.3.1 China to register highest growth in Asia Pacific market
10.4.4 INDIA
10.4.4.1 Rising disposable income and demand for better health to support market growth
10.4.5 AUSTRALIA
10.4.5.1 Strong research ecosystem for NIPT to drive market
10.4.6 SOUTH KOREA
10.4.6.1 Increasing scope for genomic research to support market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
10.5.2 BRAZIL
10.5.2.1 Rising focus on clinical genomics to drive demand for NIPT
10.5.3 MEXICO
10.5.3.1 High incidence of Down syndrome to propel demand
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
10.6.2 GCC COUNTRIES
10.6.2.1 Launch of genomic initiatives to drive market
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NON-INVASIVE PRENATAL TESTING MARKET
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 R&D EXPENDITURE OF KEY PLAYERS
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.6.5.1 Company footprint
11.6.5.2 Product & service footprint
11.6.5.3 Method footprint
11.6.5.4 Application footprint
11.6.5.5 End-user footprint
11.6.5.6 Region footprint
11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.7.1 PROGRESSIVE COMPANIES
11.7.2 DYNAMIC COMPANIES
11.7.3 STARTING BLOCKS
11.7.4 RESPONSIVE COMPANIES
11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8 VALUATION & FINANCIAL METRICS
11.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT & SERVICE LAUNCHES
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 ILLUMINA, INC.
12.1.1.1 Business overview
12.1.1.2 Products & services offered
12.1.1.3 Recent developments
12.1.1.3.1 Product launches & approvals
12.1.1.3.2 Expansions
12.1.1.3.3 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 NATERA, INC.
12.1.2.1 Business overview
12.1.2.2 Products & services offered
12.1.2.3 Recent developments
12.1.2.3.1 Product & service launches and approvals
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
12.1.3.1 Business overview
12.1.3.2 Products & services offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 EUROFINS SCIENTIFIC
12.1.4.1 Business overview
12.1.4.2 Products & services offered
12.1.4.3 Recent developments
12.1.4.3.1 Service launches
12.1.4.3.2 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 F. HOFFMANN-LA ROCHE AG
12.1.5.1 Business overview
12.1.5.2 Products & services offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 REVVITY, INC.
12.1.6.1 Business overview
12.1.6.2 Products & services offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.3.2 Deals
12.1.7 THERMO FISHER SCIENTIFIC INC.
12.1.7.1 Business overview
12.1.7.2 Products & services offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.8 AGILENT TECHNOLOGIES
12.1.8.1 Business overview
12.1.8.2 Products & services offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 GE HEALTHCARE TECHNOLOGIES INC.
12.1.9.1 Business overview
12.1.9.2 Products & services offered
12.1.9.3 Recent developments
12.1.9.3.1 Product & service launches and approvals
12.1.9.3.2 Expansions
12.1.10 QUEST DIAGNOSTICS INCORPORATED
12.1.10.1 Business overview
12.1.10.2 Products & services offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches
12.1.10.3.2 Deals
12.1.11 SONIC HEALTHCARE LIMITED
12.1.11.1 Business overview
12.1.11.2 Products & services offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.11.3.2 Expansions
12.1.12 CENTOGENE N.V.
12.1.12.1 Business overview
12.1.12.2 Products & services offered
12.1.12.3 Recent developments
12.1.12.3.1 Product launches
12.1.12.3.2 Deals
12.1.12.3.3 Other developments
12.1.13 QIAGEN N.V.
12.1.13.1 Business overview
12.1.13.2 Products & services offered
12.1.13.3 Recent developments
12.1.13.3.1 Product launches
12.1.13.3.2 Deals
12.1.13.3.3 Expansions
12.1.14 PATHWEST LABORATORY MEDICINE WA
12.1.14.1 Business overview
12.1.14.2 Products & services offered
12.1.15 MYRIAD GENETICS, INC.
12.1.15.1 Business overview
12.1.15.2 Products & services offered
12.2 OTHER PLAYERS
12.2.1 BGI GENOMICS CO., LTD.
12.2.2 OXFORD NANOPORE TECHNOLOGIES PLC
12.2.3 MEDGENOME
12.2.4 NEUBERG DIAGNOSTICS
12.2.5 ANNOROAD GENE TECHNOLOGY
12.2.6 NEXT BIOSCIENCES
12.2.7 LILAC INSIGHTS
12.2.8 INVITAE CORPORATION
12.2.9 BAYLOR GENETICS
12.2.10 RAVGEN
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 2 RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE
TABLE 3 INCIDENCE RATE OF TRISOMY
TABLE 4 COMPARISON OF NONINVASIVE AND INVASIVE PRENATAL TESTING
TABLE 5 NIPT REIMBURSEMENT SCENARIO, BY COUNTRY
TABLE 6 PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)
TABLE 7 NIPT MARKET: ECOSYSTEM ANALYSIS
TABLE 8 NIPT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NIPT PRODUCTS
TABLE 10 KEY BUYING CRITERIA FOR NIPT PRODUCTS
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 16 LIST OF PATENTS IN NIPT MARKET, 2014–2024
TABLE 17 IMPORT AND EXPORT DATA FOR NEXT-GENERATION SEQUENCING PRODUCTS,
BY COUNTRY
TABLE 18 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY TYPE
TABLE 19 AVERAGE SELLING PRICE TREND OF NIPT PRODUCTS, BY REGION
TABLE 20 NIPT MARKET: LIST OF KEY CONFERENCES AND EVENTS DURING 2024–2025
TABLE 21 NIPT MARKET: UNMET NEEDS
TABLE 22 NIPT MARKET: END-USER EXPECTATIONS
TABLE 23 NIPT MARKET: IMPACT AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE
TABLE 24 NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 25 NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 26 NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 27 NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 28 NIPT PRODUCTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 29 NIPT PRODUCTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 30 NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 31 NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 32 NIPT CONSUMABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 33 NIPT CONSUMABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 34 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 35 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 36 DISPOSABLES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 37 DISPOSABLES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 38 NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 39 NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 40 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 41 NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 42 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 43 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 44 NGS SYSTEMS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 45 NGS SYSTEMS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 46 PCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 47 PCR INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 48 MICROARRAYS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 49 MICROARRAYS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 50 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 51 OTHER NIPT INSTRUMENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 52 NIPT SERVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 53 NIPT SERVICES MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 54 NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 55 NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 56 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 57 ULTRASOUND DETECTION MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 58 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION)
TABLE 59 BIOCHEMICAL SCREENING TESTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION)
TABLE 60 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY,
2021–2023 (USD MILLION)
TABLE 61 CFDNA IN MATERNAL PLASMA TESTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION)
TABLE 62 NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 63 NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 64 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 65 NIPT MARKET FOR TRISOMY, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 66 NIPT MARKET FOR MICRODELETION SYNDROME,
BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 67 NIPT MARKET FOR MICRODELETION SYNDROME,
BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 68 NIPT MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 69 NIPT MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 70 NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 71 NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 72 NIPT MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 73 NIPT MARKET FOR DIAGNOSTIC LABORATORIES,
BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 74 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 75 NIPT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 76 NIPT MARKET, BY REGION, 2021–2023 (USD MILLION)
TABLE 77 NIPT MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 78 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 79 NORTH AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 80 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 81 NORTH AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 83 NORTH AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 84 NORTH AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 85 NORTH AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 87 NORTH AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 89 NORTH AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 91 NORTH AMERICA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 93 NORTH AMERICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 94 US: KEY MACROINDICATORS
TABLE 95 US: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 96 US: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 97 US: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 98 US: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 99 US: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 100 US: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 101 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 102 US: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 103 US: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 104 US: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 105 US: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 106 US: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 107 US: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 108 US: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 109 CANADA: KEY MACROINDICATORS
TABLE 110 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 111 CANADA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 112 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 113 CANADA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 114 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 115 CANADA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 116 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 117 CANADA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 118 CANADA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 119 CANADA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 120 CANADA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 121 CANADA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 122 CANADA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 123 CANADA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 124 EUROPE: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 125 EUROPE: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 126 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 127 EUROPE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 128 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 129 EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 130 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 131 EUROPE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 132 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 133 EUROPE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 134 EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 135 EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 136 EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 137 EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 138 EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 139 EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 140 UK: KEY MACROINDICATORS
TABLE 141 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 142 UK: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 143 UK: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 144 UK: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 145 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 146 UK: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 147 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 148 UK: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 149 UK: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 150 UK: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 151 UK: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 152 UK: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 153 UK: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 154 UK: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 155 GERMANY: KEY MACROINDICATORS
TABLE 156 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 157 GERMANY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 158 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 159 GERMANY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 160 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 161 GERMANY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 162 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 163 GERMANY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 164 GERMANY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 165 GERMANY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 166 GERMANY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 167 GERMANY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 168 GERMANY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 169 GERMANY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 170 FRANCE: KEY MACROINDICATORS
TABLE 171 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 172 FRANCE: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 173 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 174 FRANCE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 175 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 176 FRANCE: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 177 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 178 FRANCE: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 179 FRANCE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 180 FRANCE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 181 FRANCE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 182 FRANCE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 183 FRANCE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 184 FRANCE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 185 ITALY: KEY MACROINDICATORS
TABLE 186 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 187 ITALY: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 188 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 189 ITALY: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 190 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 191 ITALY: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 192 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 193 ITALY: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 194 ITALY: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 195 ITALY: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 196 ITALY: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 197 ITALY: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 198 ITALY: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 199 ITALY: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 200 SPAIN: KEY MACROINDICATORS
TABLE 201 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 202 SPAIN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 203 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 204 SPAIN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 205 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 206 SPAIN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 207 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 208 SPAIN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 209 SPAIN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 210 SPAIN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 211 SPAIN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 212 SPAIN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 213 SPAIN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 214 SPAIN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 215 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 216 REST OF EUROPE: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 217 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 218 REST OF EUROPE: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 219 REST OF EUROPE: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 220 REST OF EUROPE: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 221 REST OF EUROPE: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 222 REST OF EUROPE: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 223 REST OF EUROPE: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 224 REST OF EUROPE: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 225 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 226 REST OF EUROPE: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 227 REST OF EUROPE: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 228 REST OF EUROPE: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 229 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 230 ASIA PACIFIC: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 232 ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 233 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 234 ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 235 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 236 ASIA PACIFIC: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 237 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 238 ASIA PACIFIC: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 239 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 240 ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 241 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 242 ASIA PACIFIC: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 244 ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 245 JAPAN: KEY MACROINDICATORS
TABLE 246 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 247 JAPAN: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 248 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 249 JAPAN: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 250 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 251 JAPAN: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 252 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 253 JAPAN: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 254 JAPAN: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 255 JAPAN: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 256 JAPAN: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 257 JAPAN: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 258 JAPAN: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 259 JAPAN: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 260 CHINA: KEY MACROINDICATORS
TABLE 261 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 262 CHINA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 263 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 264 CHINA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 265 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 266 CHINA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 267 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 268 CHINA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 269 CHINA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 270 CHINA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 271 CHINA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 272 CHINA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 273 CHINA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 274 CHINA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 275 INDIA: KEY MACROINDICATORS
TABLE 276 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 277 INDIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 278 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 279 INDIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 280 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 281 INDIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 282 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 283 INDIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 284 INDIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 285 INDIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 286 INDIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 287 INDIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 288 INDIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 289 INDIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 290 AUSTRALIA: KEY MACROINDICATORS
TABLE 291 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 292 AUSTRALIA: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 293 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 294 AUSTRALIA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 295 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 296 AUSTRALIA: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 297 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 298 AUSTRALIA: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 299 AUSTRALIA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 300 AUSTRALIA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 301 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 302 AUSTRALIA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 303 AUSTRALIA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 304 AUSTRALIA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 305 SOUTH KOREA: KEY MACROINDICATORS
TABLE 306 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 307 SOUTH KOREA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 308 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 309 SOUTH KOREA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 310 SOUTH KOREA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 311 SOUTH KOREA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 312 SOUTH KOREA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 313 SOUTH KOREA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 314 SOUTH KOREA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 315 SOUTH KOREA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 316 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 317 SOUTH KOREA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 318 SOUTH KOREA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 319 SOUTH KOREA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE,
2021–2023 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: NIPT PRODUCTS MARKET, BY TYPE,
2024–2029 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 327 REST OF ASIA PACIFIC: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 328 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 329 REST OF ASIA PACIFIC: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 330 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION,
2021–2023 (USD MILLION)
TABLE 331 REST OF ASIA PACIFIC: NIPT MARKET, BY APPLICATION,
2024–2029 (USD MILLION)
TABLE 332 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 333 REST OF ASIA PACIFIC: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 334 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
TABLE 335 LATIN AMERICA: NIPT MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 336 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 337 LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 338 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 339 LATIN AMERICA: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 340 LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 341 LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 342 LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 343 LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 344 LATIN AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 345 LATIN AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 346 LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 347 LATIN AMERICA: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 348 LATIN AMERICA: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 349 LATIN AMERICA: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 350 BRAZIL: KEY MACROINDICATORS
TABLE 351 BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 352 BRAZIL: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 353 BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 354 BRAZIL: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 355 BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 356 BRAZIL: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 357 BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 358 BRAZIL: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 359 BRAZIL: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 360 BRAZIL: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 361 BRAZIL: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 362 BRAZIL: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 363 BRAZIL: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 364 BRAZIL: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 365 MEXICO: KEY MACROINDICATORS
TABLE 366 MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2021–2023 (USD MILLION)
TABLE 367 MEXICO: NIPT MARKET, BY PRODUCT & SERVICE, 2024–2029 (USD MILLION)
TABLE 368 MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 369 MEXICO: NIPT PRODUCTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 370 MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 371 MEXICO: NIPT CONSUMABLES MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 372 MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2021–2023 (USD MILLION)
TABLE 373 MEXICO: NIPT INSTRUMENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 374 MEXICO: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 375 MEXICO: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 376 MEXICO: NIPT MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
TABLE 377 MEXICO: NIPT MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 378 MEXICO: NIPT MARKET, BY END USER, 2021–2023 (USD MILLION)
TABLE 379 MEXICO: NIPT MARKET, BY END USER, 2024–2029 (USD MILLION)
TABLE 380 REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 381 REST OF LATIN AMERICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 382 REST OF LATIN AMERICA: NIPT PRODUCTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 383 REST OF LATIN AMERICA: NIPT PRODUCTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 384 REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 385 REST OF LATIN AMERICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 386 REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2021–2023 (USD MILLION)
TABLE 387 REST OF LATIN AMERICA: NIPT INSTRUMENTS MARKET,
BY TYPE, 2024–2029 (USD MILLION)
TABLE 388 REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2021–2023 (USD MILLION)
TABLE 389 REST OF LATIN AMERICA: NIPT MARKET, BY METHOD, 2024–2029 (USD MILLION)
TABLE 390 REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION,
2021–2023 (USD MILLION)
TABLE 391 REST OF LATIN AMERICA: NIPT MARKET, BY APPLICATION,
2024–2029 (USD MILLION)
TABLE 392 REST OF LATIN AMERICA: NIPT MARKET, BY END USER,
2021–2023 (USD MILLION)
TABLE 393 REST OF LATIN AMERICA: NIPT MARKET, BY END USER,
2024–2029 (USD MILLION)
TABLE 394 MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2021–2023 (USD MILLION)
TABLE 395 MIDDLE EAST & AFRICA: NIPT MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 396 MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,
2021–2023 (USD MILLION)
TABLE 397 MIDDLE EAST & AFRICA: NIPT MARKET, BY PRODUCT & SERVICE,
2024–2029 (USD MILLION)
TABLE 398 MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE,
2021–2023 (USD MILLION)
TABLE 399 MIDDLE EAST & AFRICA: NIPT PRODUCTS MARKET, BY TYPE,
2024–2029 (USD MILLION)
TABLE 400 MIDDLE EAST & AFRICA: NIPT CONSUMABLES MARKET,
BY TYPE, 2021–2023 (USD MILLION)
